Literature DB >> 17088257

Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase. A kinetic and molecular modeling analysis.

Brice Korkmaz1, Eric Hajjar, Timofey Kalupov, Nathalie Reuter, Michèle Brillard-Bourdet, Thierry Moreau, Luiz Juliano, Francis Gauthier.   

Abstract

The biological functions of human neutrophil protease 3 (Pr3) differ from those of neutrophil elastase despite their close structural and functional resemblance. Although both proteases are strongly cationic, their sequences differ mainly in the distribution of charged residues. We have used these differences in electrostatic surface potential in the vicinity of their active site to produce fluorescence resonance energy transfer (FRET) peptide substrates for investigating individual Pr3 subsites. The specificities of subsites S5 to S3' were investigated both kinetically and by molecular dynamic simulations. Subsites S2, S1', and S2' were the main definers of Pr3 specificity. Combinations of results for each subsite were used to deduce a consensus sequence that was complementary to the extended Pr3 active site and was not recognized by elastase. Similar sequences were identified in natural protein substrates such as NFkappaB and p21 that are specifically cleaved by Pr3. FRET peptides derived from these natural sequences were specifically hydrolyzed by Pr3 with specificity constants k(cat)/K(m) in the 10(6) m(-1) s(-1) range. The consensus Pr3 sequence may also be used to predict cleavage sites within putative protein targets like the proform of interleukin-18, or to develop specific Pr3 peptide-derived inhibitors, because none is available for further studies on the physiopathological function of this protease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088257     DOI: 10.1074/jbc.M608700200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Iterative Optimization of the Cyclic Peptide SFTI-1 Yields Potent Inhibitors of Neutrophil Proteinase 3.

Authors:  Sixin Tian; Joakim E Swedberg; Choi Yi Li; David J Craik; Simon J de Veer
Journal:  ACS Med Chem Lett       Date:  2019-07-19       Impact factor: 4.345

3.  Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis.

Authors:  Seda Seren; Maha Rashed Abouzaid; Claudia Eulenberg-Gustavus; Josefine Hirschfeld; Hala Nasr Soliman; Uwe Jerke; Koffi N'Guessan; Sandrine Dallet-Choisy; Adam Lesner; Conni Lauritzen; Beate Schacher; Peter Eickholz; Nikoletta Nagy; Marta Szell; Cécile Croix; Marie-Claude Viaud-Massuard; Abdullah Al Farraj Aldosari; Shivanna Ragunatha; Mostafa Ibrahim Mostafa; Francesca Giampieri; Maurizio Battino; Hélène Cornillier; Gérard Lorette; Jean-Louis Stephan; Cyril Goizet; John Pedersen; Francis Gauthier; Dieter E Jenne; Sylvain Marchand-Adam; Iain L Chapple; Ralph Kettritz; Brice Korkmaz
Journal:  J Biol Chem       Date:  2018-06-20       Impact factor: 5.157

4.  Two lytic transglycosylases in Neisseria gonorrhoeae impart resistance to killing by lysozyme and human neutrophils.

Authors:  Stephanie A Ragland; Ryan E Schaub; Kathleen T Hackett; Joseph P Dillard; Alison K Criss
Journal:  Cell Microbiol       Date:  2016-11-03       Impact factor: 3.715

5.  Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents.

Authors:  Qingliang Yang; Yi Li; Dengfeng Dou; Xiangdong Gan; Swathi Mohan; Christopher S Groutas; Laura E Stevenson; Zhong Lai; Kevin R Alliston; Jiaying Zhong; Todd D Williams; William C Groutas
Journal:  Arch Biochem Biophys       Date:  2008-04-22       Impact factor: 4.013

6.  Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.

Authors:  Brice Korkmaz; Jérôme Jaillet; Marie-Lise Jourdan; Alexandre Gauthier; Francis Gauthier; Sylvie Attucci
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

7.  Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases.

Authors:  Timofey Kalupov; Michèle Brillard-Bourdet; Sébastien Dadé; Hélène Serrano; Julien Wartelle; Nicolas Guyot; Luiz Juliano; Thierry Moreau; Azzaq Belaaouaj; Francis Gauthier
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

Review 8.  ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.

Authors:  Marshall S Horwitz; Seth J Corey; H Leighton Grimes; Timothy Tidwell
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-07       Impact factor: 3.722

9.  Inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamides.

Authors:  Yi Li; Qingliang Yang; Dengfeng Dou; Kevin R Alliston; William C Groutas
Journal:  Bioorg Med Chem       Date:  2007-10-18       Impact factor: 3.641

10.  Human neutrophil elastase responsive delivery from poly(ethylene glycol) hydrogels.

Authors:  Alex A Aimetti; Mark W Tibbitt; Kristi S Anseth
Journal:  Biomacromolecules       Date:  2009-06-08       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.